Posts Tagged ‘drug importation’
Canadian Policy Researcher Warns That Importation Plans By U.S. States Would Leave Canada Without Crucial Medicines
This editorial by Nigel Rawson was published in The Hills Times on June 9, 2019. Dr. Rawson, president of Eastlake Research Group, a senior fellow at the Fraser Institute, and an affiliated scholar with the Canadian Health Policy Institute, warns that Canada would run out of necessary medicine if U.S. states begin drug importation programs…
[...]Former State Pharmacy Board Presidents Warn That Drug Importation Won’t Keep Costs Down
This editorial by Holly Strom and Kenneth Schell published in U.S. News and World Report on May 28, 2019 warns states considering drug importation that doing so will not keep costs down and also poses a safety risk to patients…
[...]New Mexico Pharmacists Association Expresses Concern Over Allowing Drug Importation In Letter to Congress
The New Mexico Pharmacists Association recently sent their own letter to members of Congress expressing their concerns about allowing drug importation. PSM had the chance to speak with their executive director to learn more about the realities and misconceptions that people have about prescription drugs and drug importation…
[...]Head of Patient Advocacy Organization Warns That Drug Importation Is Not The Solution American Patients Need
In this editorial by Terry Wilcox published in Inside Sources on April 18, 2019, Terry Wilcox, executive director of a patient advocacy organization advices federal and state representatives that allowing drug importation is not the right policy solution for America’s high prescription drug prices…
[...]Tampa Pharmacist Speaks Out Against Florida’s Drug Importation Proposal
This editorial by Dan Fucarino was published in Florida Politics on April 1, 2019. Mr Fucarino is the owner and a pharmacist at Carrollwood Compounding Center & Pharmacy.
“The monetary rewards of Canadian prescriptions are just not worth their safety risks,” he warns. “I urge Florida legislators to listen to health care experts on this issue rather than the understandable populist appeals and vote no on this dangerous legislation — and then get back to working on more productive ways to lower drug prices for Floridians. Thousands of Americans have been injured or killed by imported prescription drugs.”
[...]Drug Importation Claim vs. Fact At Florida Senate Subcommittee Hearing
Experts and leadership from The Partnership for Safe Medicines were in Tallahassee, Florida on Monday, March 25th for a Senate hearing on an ill-advised Canadian drug importation bill. During the hearing, our team heard many false or misleading statements about the proposal to take medicine out of the Canadian medicine supply and ship it to Florida. Here’s a fact check of the most egregious ones…
[...]Florida House Bill 19 Would Expose Patients To Unregulated Prescription Drugs
Concerns over how much constituents pay for their medications have caused multiple states to introduce bills that would legalize drug importation. Florida’s House Bill 19 is just one example of legislators thinking that stepping outside the security of the U.S.’s drug supply chain is a smart option for their state…
[...]“Canadian Shelves Would Run Dry” Warns Canadian Health Economist about U.S. Proposals to Raid Canadian Drug Supply
Some politicians have suggested that allowing the importation of prescription drugs from Canada would be a safe and effective way to lower the cost of medications for Americans, but this idea overlooks a very important fact: the Canadian drug supply chain is not built to support Canada’s population and the United States’…
[...]PSM Went to Congress to Share Our Concerns About The Threat of Counterfeit Medicine
On Thursday, January 31, 2018, the Partnership for Safe Medicines held two briefings in Washington, D.C. to inform members of Congress and their staff about the dangers posed to Americans by counterfeit medicines. The events each had three panels and looked at how fake medicines have affected individuals and law enforcement, and also at the roles played by international bad actors and drug cartels…
[...]Drug Importation and the Deadly Challenge of Screening 275 Million Packages a Year
The Food and Drug Administration (FDA) in their report U.S. Food and Drug Administration and the International Mail Facilities (IMFs), describes the daunting job that Customs and Border Protection (CBP) faces when attempting to weed out counterfeit medications and packages containing illicit fentanyl. In 2017, IMFs received 275 million packages. Of these, 10,000 were screened by CBP, and of those 86% contained drugs. The investigation of a suspect package is incredibly time-consuming; an experienced FDA investigator might take as long as 20 minutes to process a package containing just on product.
[...]